August 25th, 2016
EpipPen backlash: Will price-gouging allegations spur government investigation?
Mylan Pharmaceuticals, maker of the life-saving EpiPen, is the target of outrage in the wake of reports that the price of the injectors has skyrocketed in the last 10 years while CEO Heather Bresch’s pay increased to nearly $19 million. The company says a savings card will reduce the product’s price. NBC’s Tom Costello reports for TODAY from Washington, D.C.